NASDAQ:XAGE - Nasdaq - US1429221039 - Common Stock - Currency: USD
0.165
-0.01 (-5.98%)
The current stock price of XAGE is 0.165 USD. In the past month the price increased by 21.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.33 | 351.09B | ||
AMGN | AMGEN INC | 13.55 | 151.20B | ||
GILD | GILEAD SCIENCES INC | 13.4 | 129.08B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1728.1 | 128.84B | ||
REGN | REGENERON PHARMACEUTICALS | 13.67 | 65.39B | ||
ARGX | ARGENX SE - ADR | 341.93 | 39.67B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 33.74B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.57B | ||
BNTX | BIONTECH SE-ADR | N/A | 25.23B | ||
NTRA | NATERA INC | N/A | 21.18B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 20.72B | ||
BIIB | BIOGEN INC | 7.81 | 18.10B |
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
LONGEVITY HEALTH HOLDINGS IN
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 15
Phone: 14128948248
The current stock price of XAGE is 0.165 USD. The price decreased by -5.98% in the last trading session.
The exchange symbol of LONGEVITY HEALTH HOLDINGS IN is XAGE and it is listed on the Nasdaq exchange.
XAGE stock is listed on the Nasdaq exchange.
LONGEVITY HEALTH HOLDINGS IN (XAGE) has a market capitalization of 4.97M USD. This makes XAGE a Nano Cap stock.
LONGEVITY HEALTH HOLDINGS IN (XAGE) currently has 15 employees.
LONGEVITY HEALTH HOLDINGS IN (XAGE) has a support level at 0.15. Check the full technical report for a detailed analysis of XAGE support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
XAGE does not pay a dividend.
LONGEVITY HEALTH HOLDINGS IN (XAGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.5).
The outstanding short interest for LONGEVITY HEALTH HOLDINGS IN (XAGE) is 19.12% of its float. Check the ownership tab for more information on the XAGE short interest.
ChartMill assigns a technical rating of 4 / 10 to XAGE.
Over the last trailing twelve months XAGE reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 74.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -703.41% | ||
ROE | N/A | ||
Debt/Equity | N/A |